• Something wrong with this record ?

Investigation of Anti-Inflammatory Potential of N-Arylcinnamamide Derivatives

J. Hošek, J. Kos, T. Strhársky, L. Černá, P. Štarha, J. Vančo, Z. Trávníček, F. Devínsky, J. Jampílek,

. 2019 ; 24 (24) : . [pub] 20191211

Language English Country Switzerland

Document type Journal Article

Grant support
APVV-17-0373 Slovak Research and Development Agency
LO1305 Ministry of Education, Youth and Sports of the Czech Republic
ITMS 26240120034 Center of Excellence in Security Research

A series of sixteen ring-substituted N-arylcinnamanilides, previously described as highly antimicrobially effective against a wide spectrum of bacteria and fungi, together with two new derivatives from this group were prepared and characterized. Moreover, the molecular structure of (2E)-N-(2-bromo-5-fluorophenyl)-3-phenylprop-2-enamide as a model compound was determined using single-crystal X-ray analysis. All the compounds were tested for their anti-inflammatory potential, and most tested compounds significantly attenuated the lipopolysaccharide-induced NF-κB activation and were more potent than the parental cinnamic acid. (2E)-N-[2-Chloro-5-(trifluoromethyl)phenyl]-3-phenylprop-2-enamide, (2E)-N-(2,6-dibromophenyl)- 3-phenylprop-2-enamide, and (2E)-N-(2,5-dichlorophenyl)-3-phenylprop-2-enamide demonstrated the highest inhibition effect on transcription factor NF-κB at the concentration of 2 µM and showed a similar effectiveness as the reference drug prednisone. Several compounds also decreased the level of TNF-α. Nevertheless, subsequent tests showed that the investigated compounds affect neither IκBα level nor MAPKs activity, which suggests that the N-arylcinnamanilides may have a different mode of action to prednisone. The modification of the C(2,5)' or C(2,6)' positions of the anilide core by rather lipophilic and bulky moieties seems to be preferable for the anti-inflammatory potential of these compounds.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023341
003      
CZ-PrNML
005      
20201214125810.0
007      
ta
008      
201125s2019 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/molecules24244531 $2 doi
035    __
$a (PubMed)31835703
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Hošek, Jan $u Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacký University, Šlechtitelů 27, 78371 Olomouc, Czech Republic.
245    10
$a Investigation of Anti-Inflammatory Potential of N-Arylcinnamamide Derivatives / $c J. Hošek, J. Kos, T. Strhársky, L. Černá, P. Štarha, J. Vančo, Z. Trávníček, F. Devínsky, J. Jampílek,
520    9_
$a A series of sixteen ring-substituted N-arylcinnamanilides, previously described as highly antimicrobially effective against a wide spectrum of bacteria and fungi, together with two new derivatives from this group were prepared and characterized. Moreover, the molecular structure of (2E)-N-(2-bromo-5-fluorophenyl)-3-phenylprop-2-enamide as a model compound was determined using single-crystal X-ray analysis. All the compounds were tested for their anti-inflammatory potential, and most tested compounds significantly attenuated the lipopolysaccharide-induced NF-κB activation and were more potent than the parental cinnamic acid. (2E)-N-[2-Chloro-5-(trifluoromethyl)phenyl]-3-phenylprop-2-enamide, (2E)-N-(2,6-dibromophenyl)- 3-phenylprop-2-enamide, and (2E)-N-(2,5-dichlorophenyl)-3-phenylprop-2-enamide demonstrated the highest inhibition effect on transcription factor NF-κB at the concentration of 2 µM and showed a similar effectiveness as the reference drug prednisone. Several compounds also decreased the level of TNF-α. Nevertheless, subsequent tests showed that the investigated compounds affect neither IκBα level nor MAPKs activity, which suggests that the N-arylcinnamanilides may have a different mode of action to prednisone. The modification of the C(2,5)' or C(2,6)' positions of the anilide core by rather lipophilic and bulky moieties seems to be preferable for the anti-inflammatory potential of these compounds.
650    _2
$a antiflogistika $x chemická syntéza $x chemie $x farmakologie $7 D000893
650    _2
$a cinnamáty $x chemická syntéza $x chemie $x farmakologie $7 D002934
650    _2
$a krystalografie rentgenová $7 D018360
650    _2
$a regulace genové exprese $x účinky léků $7 D005786
650    _2
$a lidé $7 D006801
650    _2
$a lipopolysacharidy $x škodlivé účinky $7 D008070
650    _2
$a molekulární modely $7 D008958
650    _2
$a molekulární struktura $7 D015394
650    _2
$a NF-kappa B $x metabolismus $7 D016328
650    _2
$a signální transdukce $x účinky léků $7 D015398
650    _2
$a THP-1 buňky $7 D000074084
650    _2
$a TNF-alfa $x metabolismus $7 D014409
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kos, Jiří $u Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacký University, Šlechtitelů 27, 78371 Olomouc, Czech Republic.
700    1_
$a Strhársky, Tomáš $u Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacký University, Šlechtitelů 27, 78371 Olomouc, Czech Republic.
700    1_
$a Černá, Lucie $u Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacký University, Šlechtitelů 27, 78371 Olomouc, Czech Republic.
700    1_
$a Štarha, Pavel $u Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacký University, Šlechtitelů 27, 78371 Olomouc, Czech Republic.
700    1_
$a Vančo, Ján $u Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacký University, Šlechtitelů 27, 78371 Olomouc, Czech Republic.
700    1_
$a Trávníček, Zdeněk $u Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacký University, Šlechtitelů 27, 78371 Olomouc, Czech Republic.
700    1_
$a Devínsky, Ferdinand $u Faculty of Pharmacy, Comenius University, Odbojárov 10, 83232 Bratislava, Slovakia.
700    1_
$a Jampílek, Josef $u Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacký University, Šlechtitelů 27, 78371 Olomouc, Czech Republic. Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovičova 6, 84215 Bratislava, Slovakia.
773    0_
$w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 24, č. 24 (2019)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31835703 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214125809 $b ABA008
999    __
$a ok $b bmc $g 1595660 $s 1114017
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 24 $c 24 $e 20191211 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
GRA    __
$a APVV-17-0373 $p Slovak Research and Development Agency
GRA    __
$a LO1305 $p Ministry of Education, Youth and Sports of the Czech Republic
GRA    __
$a ITMS 26240120034 $p Center of Excellence in Security Research
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...